Edition:
India

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.12USD
1:30am IST
Change (% chg)

$-0.09 (-43.35%)
Prev Close
$0.20
Open
$0.10
Day's High
$0.12
Day's Low
$0.10
Volume
12,100,203
Avg. Vol
111,656
52-wk High
$2.56
52-wk Low
$0.10

About

ContraVir Pharmaceuticals, Inc. is focused on curing hepatitis B through the combination of direct and indirect acting antiviral compounds. Its two assets tenofovir exalidex, or TXL, and CRV431 have complementary mechanisms of action and have shown potential synergy against hepatitis B virus (HBV). TXL is designed to deliver... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 78.00
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates